Diversified Trust’s Maravai LifeSciences MRVI Stock Holding History

Diversified Trust’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-11,221	Closed	-$319K	–	810
2022 Q2	$319K	Sell	11,221 -5,200	-32%	-$165K	0.01%	544
2022 Q1	$579K	Buy	16,421 +1,546	+10%	+$51.8K	0.02%	402
2021 Q4	$623K	Buy	14,875 +1,500	+11%	+$60.8K	0.02%	386
2021 Q3	$656K	Sell	13,375 -340	-2%	-$16.6K	0.02%	317
2021 Q2	$572K	Buy	13,715 +6,990	+104%	+$271K	0.02%	356
2021 Q1	$240K	Buy	+6,725	New	+$223K	0.01%	630

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Diversified Trust's MRVI Position: Q3 2022 in Review

Diversified Trust sold out of Maravai LifeSciences (MRVI) in Q3 2022, closing a stake of 11,221 shares — an estimated $319K sold.

Diversified Trust first reported a position in MRVI in Q1 2021 and held it in 6 quarters. The position peaked at $656K in Q3 2021. 202 funds tracked by Wall St. Rank hold MRVI as of Q3 2022.

Diversified Trust reported no remaining Maravai LifeSciences position as of Q3 2022 after selling out during the quarter.
Diversified Trust sold 11,221 Maravai LifeSciences shares in Q3 2022, an estimated $319K.
Diversified Trust first reported a position in Maravai LifeSciences in Q1 2021 and held it in 6 quarters.
Diversified Trust's Maravai LifeSciences position peaked at $656K in Q3 2021.
202 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2022.

Based on Diversified Trust's 13F filing for Q3 2022, filed 14 Oct 2022.